COVID-19 update: Genoskin to maintain US production activity during pandemic.
Genoskin COVID-19 research preferred access program On Friday, March 13th 2020,
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Genoskin reproduces ex vivo the process of apomorphine-induced panniculitis
13 January 2021
We are hiring! Join our team as a VIE Junior Web Developer!
15 December 2020
Internship offer: Join Genoskin’s Marketing team!
8 December 2020
Internship offer: Join Genoskin’s Business Development team!
We are hiring! Join our team as a Study Director!
7 December 2020